-
American Heart Assn, Amazon Partner on Cloud Analytics
American Heart Association is offering grants for new computational tools against heart disease, with Amazon Web Services providing cloud computing resources.
-
Leukemia T-Cell Trial Stopped After Patients’ Deaths
FDA halted a clinical trial testing engineered T-cells as a treatment for leukemia, after 3 participants died. Update: Juno to resume engineered T-cell trial.
-
Drug Reconciliation Program Cuts Hospital Readmission
Consultations with pharmacists on medications when patients leave the hospital for home are shown to reduce the rate of readmission to the hospital by half.
-
Small Business Grant Funds R&D on New Antibiotics
A spin-off company from University of Utah received funding to develop a new antibiotic that targets the genetics of bacteria becoming resistant to antibiotics.
-
RNA Technology Licensed for Cystic Fibrosis Therapy
Two biotechnology companies are collaborating on treatments for cystic fibrosis that use genetic material to address underlying causes of the inherited disease.
-
New Leukemia Target, Drug Candidate Discovered
An industry-academic research team identified a new target for acute myeloid leukemia, and tested a new drug that stops the growth of these cancer cells.
-
RNA Technology Allows for Fast Vaccine Development
Engineers at MIT designed a process using genetic material in nanoscale particles for vaccines that protected against dangerous diseases with a single dose.
-
Independence Day 2016
It’s the Fourth of July, a.k.a. Independence Day, in the U.S. today, so Science & Enterprise is taking the day off.
-
Bacterial-Biopolymer Delivery System Designed for Vaccines
A biotechnology company and university lab developed a vaccine delivery technique that induces an immune response, combining bacteria and a polymer material.
-
Hundreds of U.S. Clinics Found Selling Stem Cell Services
A comprehensive Internet search finds nearly 600 clinics in the U.S. claiming to offer stem cell treatments, many having dubious scientific or medical validity.